Project Grant R01DA062041

Award Date 6/1/25
Completion Date 2/28/30
Dollars Obligated $1M
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Charleston, SC 29425, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $284,040 to the Lieber Institute for Brain Development to conduct research on the molecular mechanisms underlying opioid addiction. The project aims to use integrated single-cell and spatial transcriptomic approaches to map gene expression changes in specific cell populations and projection neurons within the habenula, a key brain region...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the CFDA 93.279 Drug Use and Addiction Research Programs, provides $751,043 to investigate the cellular and molecular mechanisms underlying the complex co-morbidity of opioid use disorder (OUD), major depressive disorder (MDD), and HIV infection in the human brain. The research will use advanced techniques like single nuclei RNA sequencing (snRNA-seq) and single-nucleus assay for transposase-accessible...
This $267,310 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research at the University of Miami to investigate the role of parabrachial CGRP neurons in opioid reinforcement and withdrawal. The project aims to assess the functional role of these neurons in opioid-related behaviors and determine the associated gene expression and epigenetic changes. Specifically, the researchers will inhibit the...
This $373,300 Project Grant was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) federal grant program. The award supports research to investigate the role of the nucleus accumbens (NAc) brain region in learning associations between environmental cues and rewards, which is critical for understanding and potentially treating substance use disorders. The research aims to use optogenetic inhibition and two-photon imaging...
The National Institute on Drug Abuse (NIDA) awarded a $1,100,864 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to The Trustees of Columbia University in the City of New York, Health Sciences Division, for a 3-year period from September 30, 2024 to September 29, 2027. The grant aims to develop principled techniques for integrating large-scale electron microscopy (EM) datasets on neuronal connectivity with functional and behavioral recordings to build and benchmark...
This $207,910 federal Project Grant award was provided by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), to the Regents of the University of Michigan. The purpose of this 3-year research project is to examine the contribution of pathway-specific neural activity to individual and sex differences in the attribution of salience to emotional cues, in order to better understand the neurobiology underlying addiction and co-occurring...
The National Institute on Drug Abuse (NIDA) awarded a $592,998 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The University of Texas at El Paso (UTEP) to conduct research on the role of striosomal circuitry in driving drug-taking behavior in the face of cost. The project aims to validate a computational model of costly drug-taking during craving states, using electrophysiology, optogenetics, and advanced modeling techniques to determine the impact of the...
This $858,600 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research at the University of Pittsburgh to identify G protein-coupled receptors (GPCRs) expressed by somatostatin-expressing inhibitory neurons in the prefrontal cortex that could be targeted for the development of new treatments for opioid use disorder (OUD). The goal is to take an unbiased transcriptomics approach to find GPCR targets that...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to investigate rapid protein translation in nucleus accumbens neurons in response to a cocaine-associated cue. The $234,000 award, with a period of performance from April 15, 2025 to March 31, 2027, will be executed by Oregon Health & Science University (OHSU). The key objectives of this research project are to use translating...
This $715,238 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is focused on conducting a large-scale genome-wide association study (GWAS) to elucidate the genetic basis of opioid-related traits and opioid use disorder (OUD). The key objectives are to: 1) Deploy a survey to 500,000 diverse participants from 23andMe to collect data on pre-addiction phenotypes (e.g., initial opioid use, subjective opioid response)...

This federal Project Grant award of $1,039,420 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a comprehensive study to characterize the transcriptomic profiles and causal functions of neuronal ensembles within key brain circuits that underlie the facilitation and disinhibition of alcohol and opioid seeking behaviors. The grant, awarded to the Medical University of South Carolina, will employ innovative techniques such as single-nucleus RNA sequencing, spatial sequencing, in vivo calcium imaging, and single-cell optogenetics to map the molecular and functional organization of specific neuronal projections from the dorsomedial prefrontal cortex and paraventricular thalamus to the nucleus accumbens. The overarching goal is to provide a transformative understanding of the gene expression patterns and targetable substrates within these relevant cell populations, which can inform future treatment strategies for opioid and alcohol use disorders. The project will generate large-scale multimodal datasets that will be made freely available to the scientific community for further study.

Generated 6/17/25, 4:19 AM